Raquel Alvarado

Raquel Alvarado

Auto-generated profile, based on publicly available information

Raquel Alvarado

Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research University of New South Wales Sydney Australia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2018 in American Journal of Rhinology & Allergy
Verified
Journal Article
Open access
JHJacqueline Ho
Jacqueline Ho
AHAneeza W. Hamizan
Aneeza W. Hamizan
RARaquel Alvarado
Raquel Alvarado
JRJanet Rimmer
Janet Rimmer
WSWilliam A. Sewell
William A. Sewell
RHRichard J. Harvey
Richard J. Harvey
Background: Eosinophilic chronic rhinosinusitis (eCRS) is linked with skewed T-helper 2 or immunoglobulin E (IgE)-mediated allergic responses, with differing diagnosis, prognosis, and management to non-eCRS. Objective: The association between biomarkers and eCRS was investigated to assess the predictors of eCRS. Methods: A cross-sectional study of adult patients with chronic rhinosinusitis (CRS) undergoing endoscopic sinus surgery was conducted. eCRS was defined by histopathological assessment showing >10 eosinophils/high-power field on sinus mucosal biopsy. Blood tests were performed preoperatively and assessed for a full blood count including eosinophils and a white cell count (WCC) as well as biochemical markers of inflammation and atopy including Immunoglobulin E (IgE), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and ImmunoCAP testing for serum-specific IgE. Comparisons between eCRS and non-eCRS patients were performed. Results: 345 patients (48.1% female, age 48.72 ± 15.06 years) were recruited, with 206 (59.7%) identified as eCRS, 41% with asthma and 47% CRS with nasal polyps. eCRS patients were more likely to have asthma ( P < .01) and nasal polyps ( P < .01). Blood eosinophils were significantly elevated in eCRS (0.42±0.34 vs 0.17±0.13 × 10 9 /L, P < .01) as were eosinophils as a ratio of WCC (6.21 ± 4.48 vs 2.55 ± 1.84, P < .01). ESR was decreased when compared with non-eCRS (8.1±7.87 vs 10.65±11.91, P = .03). Receiver operating characteristic curve analysis predicted high tissue eosinophilia at blood eosinophil levels above 0.24 × 10 9 /L (sensitivity 70.9%, specificity 78.4%, area under the curve [AUC]: 0.792, P < .01). eCRS was predicted at eosinophil above 4.27% of total WCC (sensitivity 64.1%, specificity 88.5%, AUC 0.797; P < .01; positive predictive value 89.2%, negative predictive value 62.4%, positive likelihood ratio 5.57, and diagnostic odds ratio 13.71). There was no significant association among WCC, CRP, IgE, or ImmunoCAP testing. Conclusion: eCRS is associated with elevated blood eosinophils (>0.24 × 10 9 /L), eosinophil ratio (>4.27% of total WCC), and lower ESR when compared with non-eCRS.

20 July 2020 in Pituitary
Verified
Journal Article
Closed access
PDF file
ASAnna Stroud
Anna Stroud
PDPearl Dhaliwal
Pearl Dhaliwal
RARaquel Alvarado
Raquel Alvarado
MWMark J. Winder
Mark J. Winder
BJBenjamin P. Jonker
Benjamin P. Jonker
AMAnn McCormack
Ann McCormack

7 August 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
Mark W RobinsonMark W Robinson
Mark W Robinson
RARaquel Alvarado
Raquel Alvarado
JTJoyce To
Joyce To
AHAndrew T. Hutchinson
Andrew T. Hutchinson
SDStephanie N. Dowdell
Stephanie N. Dowdell
SDSheila Donnelly
Sheila Donnelly
We previously reported the identification of a novel family of immunomodulatory proteins, termed helminth defense molecules (HDMs), that are secreted by medically important trematode parasites. Since HDMs share biochemical, structural, and functional characteristics with mammalian cathelicidin‐like host defense peptides (HDPs), we proposed that HDMs modulate the immune response via molecular mimicry of host molecules. In the present study, we report the mechanism by which HDMs influence the function of macrophages. We show that the HDM secreted by Fasciola hepatica (FhHDM‐1) binds to macrophage plasma membrane lipid rafts via selective interaction with phospholipids and/or cholesterol before being internalized by endocytosis. Following internalization, FhHDM‐1 is rapidly processed by lysosomal cathepsin L to release a short C‐terminal peptide (containing a conserved amphipathic helix that is a key to HDM function), which then prevents the acidification of the endolysosomal compartments by inhibiting vacuolar ATPase activity. The resulting endolysosomal alkalization impedes macrophage antigen processing and prevents the transport of peptides to the cell surface in conjunction with MHC class II for presentation to CD4 + T cells. Thus, we have elucidated a novel mechanism by which helminth pathogens alter innate immune cell function to assist their survival in the host.—Robinson, M. W., Alvarado, R., To, J., Hutchinson, A. T., Dowdell, S. N., Lund, M., Turnbull, L., Whitchurch, C. B., O'Brien, B. A., Dalton, J. P., Donnelly, S. A helminth cathelicidin‐like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase. FASEB J. 26, 4614–4627 (2012). www.fasebj.org

30 March 2018 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
AHAneeza W. Hamizan
Aneeza W. Hamizan
PLPatricia A. Loftus
Patricia A. Loftus
RARaquel Alvarado
Raquel Alvarado
JHJacqueline Ho
Jacqueline Ho
LKLarry Kalish
Larry Kalish
RHRichard J. Harvey
Richard J. Harvey

28 September 2016 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
RARaquel Alvarado
Raquel Alvarado
JTJoyce To
Joyce To
MLMaria Lund
Maria Lund
APAnita Pinar
Anita Pinar
AMAshley Mansell
Ashley Mansell
SDSheila Donnelly
Sheila Donnelly
The NLRP3 inflammasome is a multimeric protein complex that controls the production of IL‐1β, a cytokine that influences the development of both innate and adaptive immune responses. Helminth parasites secrete molecules that interact with innate immune cells, modulating their activity to ultimately determine the phenotype of differentiated T cells, thus creating an immune environment that is conducive to sustaining chronic infection. We show that one of these molecules, FhHDM‐1, a cathelicidin‐like peptide secreted by the helminth parasite, Fasciola hepatica , inhibits the activation of the NLRP3 inflammasome resulting in reduced secretion of IL‐1β by macrophages. FhHDM‐1 had no effect on the synthesis of pro‐IL‐1β. Rather, the inhibitory effect was associatedwith the capacity of the peptide to prevent acidification of the endolysosome. The activation of cathepsin B protease by lysosomal destabilization was prevented in FhHDM‐1‐treated macrophages. By contrast, peptide derivatives of FhHDM‐1 that did not alter the lysosomal pH did not inhibit secretion of IL‐1β. Wepropose a novel immunemodulatory strategy usedby F. hepatica , whereby secretion of the FhHDM‐1 peptide impairs the activation of NLRP3 by lysosomal cathepsin B protease, which prevents the downstream production of IL‐1β and the development of protective T helper 1 type immune responses that are detrimental to parasite survival.—Alvarado, R., To, J., Lund, M. E., Pinar, A., Mansell, A., Robinson, M. W., O'Brien, B. A., Dalton, J. P., Donnelly, S. The immune modulatory peptide FhHDM‐1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophages. FASEB J. 31, 85–95 (2017) www.fasebj.org

20 July 2017 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
AHAneeza W. Hamizan
Aneeza W. Hamizan
JRJanet Rimmer
Janet Rimmer
RARaquel Alvarado
Raquel Alvarado
WSWilliam A. Sewell
William A. Sewell
LKLarry Kalish
Larry Kalish
RHRichard J. Harvey
Richard J. Harvey